» Articles » PMID: 36829143

Large-scale in Vitro Microdosimetry Via Live Cell Microscopy Imaging: Implications for Radiosensitivity and RBE Evaluations in Alpha-emitter Radiopharmaceutical Therapy

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2023 Feb 24
PMID 36829143
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Alpha-emitter radiopharmaceutical therapy (αRPT) has shown promising outcomes in metastatic disease. However, the short range of the alpha particles necessitates dosimetry on a near-cellular spatial scale. Current knowledge on cellular dosimetry is primarily based on in vitro experiments using cell monolayers. The goal of such experiments is to establish cell sensitivity to absorbed dose (AD). However, AD cannot be measured directly and needs to be modeled. Current models, often idealize cells as spheroids in a regular grid (geometric model), simplify binding kinetics and ignore the stochastic nature of radioactive decay. It is unclear what the impact of such simplifications is, but oversimplification results in inaccurate and non-generalizable results, which hampers the rigorous study of the underlying radiobiology.

Methods: We systematically mapped out 3D cell geometries, clustering behavior, agent binding, internalization, and subcellular trafficking kinetics for a large cohort of live cells under representative experimental conditions using confocal microscopy. This allowed for realistic Monte Carlo-based (micro)dosimetry. Experimentally established surviving fractions of the HER2 + breast cancer cell line treated with a Pb-labelled anti-HER2 conjugate or external beam radiotherapy, anchored a rigorous statistical approach to cell sensitivity and relative biological effectiveness (RBE) estimation. All outcomes were compared to a reference geometric model, which allowed us to determine which aspects are crucial model components for the proper study of the underlying radiobiology.

Results: In total, 567 cells were measured up to 26 h post-incubation. Realistic cell clustering had a large (2x), and cell geometry a small (16.4% difference) impact on AD, compared to the geometric model. Microdosimetry revealed that more than half of the cells do not receive any dose for most of the tested conditions, greatly impacting cell sensitivity estimates. Including these stochastic effects in the model, resulted in significantly more accurate predictions of surviving fraction and RBE (permutation test; p < .01).

Conclusions: This comprehensive integration of the biological and physical aspects resulted in a more accurate method of cell survival modelling in αRPT experiments. Specifically, including realistic stochastic radiation effects and cell clustering behavior is crucial to obtaining generalizable radiobiological parameters.

Citing Articles

Impact of cell geometry, cellular uptake region, and tumour morphology on Ac and Lu dose distributions in prostate cancer.

Miller C, Klyuzhin I, Chausse G, Brosch-Lenz J, Koniar H, Shi K EJNMMI Phys. 2024; 11(1):97.

PMID: 39570450 PMC: 11582247. DOI: 10.1186/s40658-024-00700-9.


Estimation of relative biological effectiveness of Ac compared to Lu during [Ac]Ac-PSMA and [Lu]Lu-PSMA radiopharmaceutical therapy using TOPAS/TOPAS-nBio/MEDRAS.

Rumiantcev M, Li W, Lindner S, Liubchenko G, Resch S, Bartenstein P EJNMMI Phys. 2023; 10(1):53.

PMID: 37695374 PMC: 10495309. DOI: 10.1186/s40658-023-00567-2.

References
1.
Pouget J, Constanzo J . Revisiting the Radiobiology of Targeted Alpha Therapy. Front Med (Lausanne). 2021; 8:692436. PMC: 8353448. DOI: 10.3389/fmed.2021.692436. View

2.
Huang C, Guatelli S, Oborn B, Allen B . Microdosimetry for targeted alpha therapy of cancer. Comput Math Methods Med. 2012; 2012:153212. PMC: 3439982. DOI: 10.1155/2012/153212. View

3.
Frelin-Labalme A, Roger T, Falzone N, Lee B, Sibson N, Vallis K . Radionuclide spatial distribution and dose deposition for in vitro assessments of Pb-αVCAM-1 targeted alpha therapy. Med Phys. 2019; 47(3):1317-1326. DOI: 10.1002/mp.13969. View

4.
Langen K, Papanikolaou N, Balog J, Crilly R, Followill D, Goddu S . QA for helical tomotherapy: report of the AAPM Task Group 148. Med Phys. 2010; 37(9):4817-53. DOI: 10.1118/1.3462971. View

5.
Sgouros G, Bodei L, McDevitt M, Nedrow J . Radiopharmaceutical therapy in cancer: clinical advances and challenges. Nat Rev Drug Discov. 2020; 19(9):589-608. PMC: 7390460. DOI: 10.1038/s41573-020-0073-9. View